| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 7W2581Z5L8 |
| InChI Key | RYIDHLJADOKWFM-MAODMQOUSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H26N2O4 |
| Molecular Weight | 370.45 |
| AlogP | 1.25 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 103.86 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 27.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Mu opioid receptor antagonist | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Opioid receptor
|
- | - | - | 0 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Feeding and Eating Disorders | 2 | D001068 | ClinicalTrials |
| Schizophrenia | 2 | D012559 | ClinicalTrials |
| Alcoholism | 2 | D000437 | ClinicalTrials |
| Cocaine-Related Disorders | 1 | D019970 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 852626-89-2 |
| ChEMBL | CHEMBL426084 |
| DrugBank | DB12543 |
| FDA SRS | 7W2581Z5L8 |
| Guide to Pharmacology | 10651 |
| PubChem | 11667832 |
| SureChEMBL | SCHEMBL2786239 |
| ZINC | ZINC000028478244 |